Current evidence does not support a clear clinical advantage of FC in reducing TSH or improving postoperative outcomes in LMBS. Considering the potential for increased postoperative pain and substantial interstudy heterogeneity, decisions regarding FC should be individualized. Larger multicenter RCTs with standardized techniques and longer follow-up are warranted.
Zhu et al. (Wed,) studied this question.